Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > OCGN Ocugen > Detailed Quotes

OCGN Ocugen

Watchlist
1.290
-0.040-3.01%
Close  02/03 16:00 ET
1.2900.0000.00%
Post Mkt Price 02/03 19:58 ET
High
1.350
Open
1.290
Turnover
6.51M
Low
1.270
Pre Close
1.330
Volume
4.98M
Market Cap
282.36M
P/E(TTM)
Loss
52wk High
4.530
Shares
218.89M
P/E(Static)
Loss
52wk Low
1.090
Float Cap
272.88M
Bid/Ask %
88.49%
Historical High
778.200
Shs Float
211.53M
Volume Ratio
0.85
Historical Low
0.170
Dividend TTM
--
Div Yield TTM
--
P/B
2.97
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2.36%
Amplitude
6.02%
Avg Price
1.306
Lot Size
1
Float Cap
272.88M
Bid/Ask %
88.49%
Historical High
778.200
Shs Float
211.53M
Volume Ratio
0.85
Historical Low
0.170
Dividend TTM
--
P/B
2.97
Dividend LFY
--
Turnover Ratio
2.36%
Amplitude
6.02%
Avg Price
1.306
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
CEO: Dr. Shankar Musunuri, M.B.A.,PhD
Market: NASDAQ
Listing Date: 12/03/2014
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist